Document:

EX-4.4

 Exhibit 4.4 

ONEOK PARTNERS, L.P. 

Issuer; 
 ONEOK PARTNERS
INTERMEDIATE LIMITED PARTNERSHIP 
 and 

ONEOK, Inc. 
 Guarantors;

 and 
 WELLS FARGO
BANK, N.A. 
 Trustee 

FIFTEENTH SUPPLEMENTAL INDENTURE 

Dated as of June 30, 2017 

to 
 INDENTURE 

Relating to Senior Debt Securities 

Dated as of September 25, 2006 

2.000% Senior Notes due 2017 

3.200% Senior Notes due 2018 

8.625% Senior Notes due 2019 

3.80% Senior Notes due 2020 

3.375% Senior Notes due 2022 

5.000% Senior Notes due 2023 

4.90% Senior Notes due 2025 

6.65% Senior Notes due 2036 

6.85% Senior Notes due 2037 

6.125% Senior Notes due 2041 

6.200% Senior Notes due 2043 

 FIFTEENTH SUPPLEMENTAL INDENTURE, dated as of June 30, 2017 (this
“Supplemental Indenture”), among ONEOK PARTNERS, L.P., a Delaware limited partnership (the “Partnership”), ONEOK PARTNERS INTERMEDIATE LIMITED PARTNERSHIP, a Delaware limited partnership (the “Existing
Guarantor”), ONEOK, Inc., an Oklahoma corporation (the “Parent Guarantor” and, together with the Existing Guarantor, the “Guarantors”), and WELLS FARGO BANK, N.A., as trustee under the Indenture referred to
below (in such capacity, the “Trustee”). 
 RECITALS 

WHEREAS, the Partnership, the Existing Guarantor and the Trustee have heretofore entered into an Indenture, dated as of
September 25, 2006 (the “Original Indenture”) (the Original Indenture, as amended and supplemented from time to time, including without limitation pursuant to this Supplemental Indenture, being referred to herein as the
“Indenture”); 
 WHEREAS, on the date hereof, pursuant to an Agreement and Plan of Merger, dated as of
January 31, 2017 (the “Merger Agreement”), among the Parent Guarantor, New Holdings Subsidiary, LLC, a Delaware limited liability company and wholly owned subsidiary of the Parent Guarantor (“Merger Sub”), the
Partnership and ONEOK Partners GP, L.L.C., a Delaware limited liability company and the general partner of the Partnership, Merger Sub merged with and into the Partnership (the “Merger”), with the Partnership surviving and
continuing to exist as a Delaware limited partnership and, as a result, the Parent Guarantor acquired all of the outstanding common units representing limited partner interests in the Partnership that the Parent Guarantor and its subsidiaries did
not already own; 
 WHEREAS, Section 9.01 of the Original Indenture provides that the Partnership, each Guarantor and the
Trustee may from time to time and at any time, without the consent of Holders, enter into a supplemental indenture to add to the covenants of the Partnership or any Guarantor such further covenants, restrictions, conditions or provisions for the
protection of the Holders of all or any series of Debt Securities as the Board of Directors shall consider to be for the protection of the Holders of such Debt Securities; 

WHEREAS, in connection with the transactions contemplated by the Merger Agreement, the Parent Guarantor desires to become a guarantor
of, and provide a guarantee of, the currently outstanding debt securities, the titles of the series and the current outstanding principal amounts thereof being set forth on Schedule A hereto (collectively, the “Currently Outstanding
Securities”); and 
 WHEREAS, this Supplemental Indenture has not resulted in a material modification of the Currently
Outstanding Securities for Foreign Account Tax Compliance Act purposes, and all things necessary to make this Supplemental Indenture a legal, valid and binding agreement of the Partnership, the Existing Guarantor and the Parent Guarantor have been
done. 
 NOW THEREFORE, in consideration of the foregoing and for other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the Parent Guarantor hereby guarantees the Partnership’s obligations under the Currently Outstanding Securities as follows: 

ARTICLE I 
 RELATION TO
INDENTURE; DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 
 Section 1.01 Relation to Indenture. With respect to the
Currently Outstanding Securities, this Supplemental Indenture constitutes an integral part of the Indenture. 

 Section 1.02 Definitions. For all purposes of this Supplemental Indenture,
capitalized terms used herein and not otherwise defined herein shall have the meanings assigned thereto in the Original Indenture. 

Section 1.03 General References. All references in this Supplemental Indenture to Articles and Sections, unless otherwise specified,
refer to the corresponding Articles and Sections of this Supplemental Indenture; and the term “herein”, “hereof”, “hereunder” and any other word of similar import refers to this Supplemental Indenture. 

ARTICLE II 
 AGREEMENT TO
GUARANTEE 
 Section 2.01 Agreement to Guarantee. 

(a) Except as provided below, the Parent Guarantor hereby agrees to provide a full and unconditional Guarantee (the “Parent
Guarantee”) on the terms and subject to the conditions set forth in Article XII of the Original Indenture. 
 (b) The Parent
Guarantee shall be terminated and discharged and shall be of no further force and effect, and the Parent Guarantor shall be automatically and unconditionally released from all of its obligations under the Parent Guarantee and the Indenture, with
respect to a series of Currently Outstanding Securities, solely upon (i) the legal defeasance, covenant defeasance or satisfaction and discharge of the Indenture with respect to such series of Currently Outstanding Securities as provided in
ARTICLE XI of the Indenture or (ii) such series of Currently Outstanding Securities ceasing to be Outstanding. 
 (c) As used in this
Supplemental Indenture and in Sections 12.01 and 12.02 of the Original Indenture only, the terms “Guarantor,” “Parent Guarantor,” “Guarantee” and “Parent Guarantee” shall include the Parent Guarantor.
Notwithstanding anything in this Supplemental Indenture to the contrary, other than with respect to this Supplemental Indenture and in Sections 12.01 and 12.02 of the Original Indenture, the Parent Guarantor will not be considered a Guarantor,
and the Parent Guarantee will not be considered a Guarantee, for any purpose under the Indenture. Therefore, other than as set forth in this Supplemental Indenture and in Sections 12.01 and 12.02 of the Original Indenture, the Parent Guarantor will
not be subject to the Indenture and will not be subject to any covenants or restrictions contained in the Indenture, including, without limitation, with respect to any merger, consolidation or sale of assets. 

Section 2.02 Benefits Acknowledged. The Parent Guarantor acknowledges that it shall receive direct and indirect benefits from the
financing arrangements contemplated by the Indenture and from the Parent Guarantee under this Supplemental Indenture. 
 Section 2.03 No
Requirement to Endorse Notation of Guarantee. The Parent Guarantor hereby agrees that its execution and delivery of this Supplemental Indenture and this ARTICLE II shall evidence its Parent Guarantee without the need for notation on any
Currently Outstanding Securities. 
 Section 2.04 Reports by the Parent Guarantor. If the Partnership is not otherwise required
to file with the SEC information, documents or other reports pursuant to the Exchange Act, then for so long as the Parent Guarantee is in effect with respect to any Currently Outstanding Securities, the Parent Guarantor shall: 

  
 2 

 (a) file with the Trustee, within 30 days after the Parent Guarantor is required to file the same
with the SEC, copies of the annual reports and of the information, documents and other reports (or copies of such portions of any of the foregoing as the SEC may from time to time by rules and regulations prescribe) which the Parent Guarantor may be
required to file with the SEC pursuant to Section 13 or Section 15(d) of the Exchange Act; or, if the Parent Guarantor is not required to file information, documents or reports pursuant to either of such Sections, then it shall file with
the Trustee and the SEC, in accordance with rules and regulations prescribed from time to time by the SEC, such of the supplementary and periodic information, documents and reports which may be required pursuant to Section 13 of the Exchange
Act in respect of a security listed and registered on a national securities exchange as may be prescribed from time to time in such rules and regulations; 

(b) file with the Trustee and the SEC, in accordance with rules and regulations prescribed from time to time by the SEC, such additional
information, documents and reports with respect to compliance by the Parent Guarantor with the conditions and covenants of this Indenture as may be required from time to time by such rules and regulations; 

(c) transmit by mail to all Holders of such Currently Outstanding Securities, as their names and addresses appear in the Debt Security
Register, within 30 days after the filing thereof with the Trustee, in the manner and to the extent provided in TIA Section 313(c), such summaries of any information, documents and reports required to be filed by the Company pursuant to
Subsections (a) and (b) of this Section 2.04 as may be required by rules and regulations prescribed from time to time by the SEC; and 

(d) Delivery of such statements, reports, notices and other information and documents to the Trustee pursuant to any of the provisions of this
Section 2.04 is for informational purposes only and the Trustee’s receipt of such shall not constitute constructive notice of any information contained therein or determinable from information contained therein, including the Partnership
or any Guarantor’s compliance with any of their covenants under the Indenture (as to which the Trustee is entitled to rely exclusively on Officers’ Certificates). The Trustee shall have no obligation whatsoever to determine whether or not
such information, documents or reports have been filed pursuant to the EDGAR filing system (or its successor) or postings to any website have occurred. 

ARTICLE III 

MISCELLANEOUS 
 Section
3.01 Notices. Notices to the Parent Guarantor shall be made in accordance with Section 13.03 of the Indenture at the address for the Partnership set forth in such Section. 

Section 3.02 No Recourse Against Others. No director, officer, employee, partner (including, for greater certainty, any general partner
of any general partnership who is an individual person), incorporator, manager, stockholder or member of the Parent Guarantor, as such, will have any liability for any obligations of the Partnership, the Parent Guarantor or any other Guarantor under
the Currently Outstanding Securities or the Indenture or for any claim based on, in respect of, or by reason of, such obligations or their creation. The waiver and release are part of the consideration for the issuance of the Parent Guarantee and
the Currently Outstanding Securities. 
 Section 3.03 Certain Trustee Matters. 

The recitals contained herein shall be taken as the statements of the Partnership and the Guarantors, and the Trustee makes no representation
as to and assumes no responsibility for their correctness. 

  
 3 

 The Trustee makes no representations as to and shall not be responsible for the validity or
sufficiency of this Supplemental Indenture, the Merger Agreement, the Merger, the Guarantee of the Existing Guarantor and the Parent Guarantor, or the proper authorization or the due execution hereof or thereof by the Partnership or any of the
Guarantors. 
 Except as expressly set forth herein, nothing in this Supplemental Indenture shall alter the duties, rights, privileges,
immunities or obligations of the Trustee set forth in the Original Indenture. In entering into this Supplemental Indenture, the Trustee shall be entitled to the benefit of every provision of the Indenture relating to the conduct or affecting the
liability of or affording protection to the Trustee, whether or not elsewhere herein so provided. 
 Section 3.04 Continued Effect.
Except as expressly supplemented and amended by this Supplemental Indenture, the Original Indenture shall continue in full force and effect in accordance with the provisions thereof, and the Original Indenture (as supplemented and amended by this
Supplemental Indenture) is in all respects hereby ratified and confirmed. This Supplemental Indenture and all its provisions shall be deemed a part of the Original Indenture in the manner and to the extent herein and therein provided. 

Section 3.05 Governing Law. This Supplemental Indenture, the Currently Outstanding Securities and the Guarantees shall be governed by
and construed in accordance with the laws of the State of New York. This Supplemental Indenture and the Currently Outstanding Securities are subject to the provisions of the Trust Indenture Act that are required to be part of this Supplemental
Indenture and the Currently Outstanding Securities and shall, to the extent applicable, be governed by such provisions. 
 Section 3.06
Counterparts. This instrument may be executed in any number of counterparts, each of which, when delivered, shall be deemed to be an original, but all such counterparts shall together constitute but one and the same instrument. The exchange
of copies of this Supplemental Indenture and of signature pages by facsimile or PDF transmission shall constitute effective execution and delivery of this Supplemental Indenture as to the parties hereto and may be used in lieu of the original
Supplemental Indenture for all purposes. Signatures of the parties hereto transmitted by facsimile or PDF shall be deemed to be their original signatures for all purposes. 

Section 3.07 Jury Trial Waiver. EACH OF THE PARTNERSHIP, THE GUARANTORS AND THE TRUSTEE HEREBY IRREVOCABLY WAIVES, TO
THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS SUPPLEMENTAL INDENTURE OR THE TRANSACTIONS CONTEMPLATED HEREBY. 

(signature page follows) 

  
 4 

 IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly
executed and delivered, all as of the day and year first above written. 
  

					
	ONEOK PARTNERS, L.P.
		
	By:	 	 ONEOK Partners GP, L.L.C.,
 its
General Partner

		
	By:	 	 /s/ Walter S. Hulse III

		 	Name:	 	Walter S. Hulse III
		 	Title:	 	 Chief Financial Officer and
 Executive Vice
President, Strategic Planning and Corporate Affairs

  

					
	ONEOK, INC.
		
	By:	 	 /s/ Terry K. Spencer

		 	Name:	 	Terry K. Spencer
		 	Title:	 	 President and Chief Executive

Officer

  

					
	ONEOK PARTNERS INTERMEDIATE LIMITED PARTNERSHIP
		
	By:	 	 ONEOK ILP GP, L.L.C.,
 its General
Partner

		
	By:	 	 /s/ Walter S. Hulse III

		 	Name:	 	Walter S. Hulse III
		 	Title:	 	 Chief Financial Officer and
 Executive Vice
President, Strategic Planning and Corporate Affairs

  

					
	 WELLS FARGO BANK, N.A., 

as Trustee

		
	By:	 	 /s/ Gregory S. Clarke

		 	Name:	 	Gregory S. Clarke
		 	Title:	 	Vice President

  
 [Signature Page to
ONEOK Supplemental Indenture] 

 Schedule A 

Currently Outstanding Securities 

$400,000,000 2.000% Senior Notes due 2017 
 $425,000,000 3.200%
Senior Notes due 2018 
 $500,000,000 8.625% Senior Notes due 2019 

$300,000,000 3.80% Senior Notes due 2020 
 $900,000,000 3.375%
Senior Notes due 2022 
 $425,000,000 5.000% Senior Notes due 2023 

$500,000,000 4.90% Senior Notes due 2025 
 $600,000,000 6.65%
Senior Notes due 2036 
 $600,000,000 6.85% Senior Notes due 2037 

$650,000,000 6.125% Senior Notes due 2041 
 $400,000,000 6.200%
Senior Notes due 2043Exhibit 10.1

LICENSE AGREEMENT

Between

ALTITUDE INTERNATIONAL INC.

and

SPORTING EDGE UK LTD., INC.

This License Agreement (“Agreement”), effective as of June 27, 2017 (the “Effective Date”), is by and between Sporting Edge UK Ltd., Inc., a UK company located at Unit J, Loddon Business Centre, Roentgen Road, Basingstoke, RG24 8NG, UK (“Licensor”), and Altitude International, Inc., a Wisconsin corporation located at 515 E. Las Olas Blvd. #120, Ft. Lauderdale, FL  33301 (“Licensee”).

WHEREAS, Licensor is the sole and exclusive owner of and has the right to license to Licensee the ability to manufacture and sell rights to the full range of membrane based systems for the production of reduced oxygen environments and associated services as well as the use of patents and trademarks held by Sporting Edge UK Ltd or David Vincent as defined below) in the Territory (as defined below); and

WHEREAS, Licensee wishes to license the Manufacturing and Sales Rights from Licensor, and Licensor is willing to grant to Licensee a license to the Manufacturing and Sales Rights on the terms and conditions set out in this Agreement.

NOW, THEREFORE, in consideration of the mutual covenants, terms and conditions set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

1. Definitions. For purposes of this Agreement, the following terms shall have the following meanings:

“Action” has the meaning set forth in Section 11.1.

“Affiliate” of a Person means any other Person that directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with, such Person. The term “control” (including the terms “controlled by” and “under common control with”) means the possession, directly or indirectly, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise.

 “Bankruptcy Code” has the meaning set forth in Section 13.1.

 “Business Day” shall mean any day of the year that is not a Saturday, Sunday or a day on which commercial banks in California are authorized or required by law to close.

“Confidential Information” means any information that is treated as confidential by either party, including trade secrets, technology, information pertaining to business operations and strategies, and information pertaining to customers, pricing and marketing, in each case to the extent it is: (a) if in tangible form, marked as confidential; or (b) otherwise, identified at the time of disclosure as confidential and confirmed in writing as such within two (2) days after disclosure. Without limiting the foregoing, Confidential Information of Licensee includes the terms and existence of this Agreement. Confidential Information does not include information that the Receiving Party can demonstrate by documentation: (w) was already known to the Receiving Party without restriction on use or disclosure prior to receipt of such information directly or indirectly from or on behalf of the Disclosing Party; (x) was or is independently developed by the Receiving Party without reference to or use of any of the Disclosing Party’s Confidential Information; (y) was or becomes generally known by the public other than by breach of this Agreement by, or other wrongful act of, the Receiving Party or any of its Representatives; or (z) was received by the Receiving Party from a Third Party who was not, at the time, under any obligation to the Disclosing Party or any other Person to maintain the confidentiality of such information.

“Manufacturing & Sales Rights” means the Manufacturing and Sales of products using the technology developed by the Licensor rights as licensed pursuant to Section 2.

“Intellectual Property (IP) Rights” means the Intellectual Property used in conjunction with the Manufacturing Distribution Rights, including any Improvements thereto and such intellectual property set forth on Schedule 1.

“Effective Date” has the meaning set forth in the preamble.

“Improvement” means (a) any new or modified distribution rights that have the same function as any of the Distribution Rights but (i) is better or more economical; (ii) is more marketable than the Distribution Rights for any reason; or (b) any enhancement or modification to the Distribution Rights and the underlying.

“Improvement Notice” has the meaning set forth in Section 3.1.

“Indemnitee” has the meaning set forth in Section 11.1.

“Intellectual Property” means shall mean all patents, trademarks, trade names, service marks, service names, trade dress, logos, copyrights and domain names, and any registrations, applications and renewals for any of the foregoing, and all other intellectual property rights in inventions, trade secrets, manufacturing processes, technology, know-how, confidential and proprietary information, ideas, developments, drawings, specifications, bills of material, supplier lists, marketing information, sales and promotional information, business plans, computer software (whether in object code (i.e., machine-readable) or source code (i.e., readable and understandable by a programmer of ordinary skill) form) and all programmer notes and other documentation and tools that would allow a programmer of ordinary skill to maintain, enhance, 

and create derivative works of such software, test reports, component lists, manuals, instructions, catalogs, processes, designs, and registrations and applications for registration therefor, model numbers, telephone numbers, web addresses, web sites, electronic records of drawings and tooling and other electronic engineering tools, and all other proprietary rights, in each case owned or licensed by such person or used in such person’s business.

“Law” means any statute, law, ordinance, regulation, rule, code, order, constitution, treaty, common law, judgment, award, decree, other requirement or rule of law of any federal, state, local or foreign government or political subdivision thereof, or any arbitrator, court or tribunal of competent jurisdiction.

“Licensee” has the meaning set forth in the preamble.

“Licensor” has the meaning set forth in the preamble.

“Losses” means all losses, damages, liabilities, deficiencies, claims, actions, judgments, settlements, interest, awards, penalties, fines, costs or expenses of whatever kind, including reasonable attorneys’ fees and the cost of enforcing any right to indemnification hereunder and the cost of pursuing any insurance providers.

“Person” means an individual, corporation, partnership, joint venture, limited liability company, governmental authority, unincorporated organization, trust, association or other entity.

“Representatives” means a Party’s and its Affiliates’ employees, officers, directors, consultants and legal advisors.

“Term” has the meaning set forth in Section 12.1.

“Territory” means the Continent of North America, Central America and the Continent of South America.

2. Grant.

2.1 Scope of Grant. Subject to the terms and conditions of this Agreement, Licensor hereby irrevocably grants to Licensee during the Term a perpetual, exclusive right and license to the Manufacturing and Sales Rights in the Territory.

2.2 Restrictions on Licensor. Licensor shall not grant others the Manufacturing & Sales Rights in the Territory.

2.3 Sublicensing. Licensor hereby grants to Licensee the right to grant sublicenses of any of its rights under this agreement in accordance with the terms of this Agreement. The granting of sublicenses shall be at the direction of the Licensor as to how many may be granted in the Territory, but Licensee shall have the power to determine the identity of any sub-licensee subject to the written approval of the Licensor, which approval shall not be unreasonably withheld by Licensor.  All of the applicable licensee fees or royalty rates, if any, and other terms and conditions of the sublicense shall be determined by solely by the Licensor.

2.4 Publicity. Licensee shall develop all of its publicity and publications of advertising and marketing materials within the Territory related to the licenses granted hereunder, which publicity and publications must be approved by Licensor, and which approval shall not be unreasonably withheld by Licensor.

2.5 Trademarks.  Licensee shall have the right to select and use Licensors’ trademarks to identify the products relating to the Distribution Rights.  Licensee acknowledges the ownership of such trademarks in Licensor and agrees that except for as expressly set forth herein, nothing in this Agreement shall be construed to grant Licensee any right, title or interest in or to any trademark used by Licensee or registered in the name of Licensor.

3. Payments.

3.1 Upfront Payment. On the Effective Date and for a period of 5 years thereafter, Licensee shall pay to Licensor Ten Thousand Dollars ($10,000) annually

3.2 Royalty.  Commencing on the 6th anniversary of the Effective Date the Licensee shall pay continuing royalty fees pursuant to the terms listed in Schedule 3, attached hereto and incorporated by reference herein.

4. Prosecution and Maintenance.

4.1 Infringement; Patent Protection and Maintenance. Licensor shall from time to time take all steps which it reasonably considers necessary to protect its rights to the Distribution Rights of Licensee, and the Licensee agrees forthwith to communicate to the Licensor any infringements or threatened infringements of the Licensor’s Distribution Rights which may come to its notice. Licensor shall have no obligation to maintain or enforce any patents that may issue and become part of the Distribution Rights and nothing in this Section 5.1 shall impose upon a Licensor any obligation to incur any expense in enforcing the Distribution Rights.

4.2 Patent Applications and Maintenance. Licensor will have sole authority and discretion to make decisions relating to whether and how to apply for, prosecute, obtain, maintain and renew the patents and applications included in the Licensor’s Distribution Rights.  Licensor shall promptly notify Licensee if Licensor declines to (i) apply for a patent, copyright, or trademark with respect to the Distribution Rights for any jurisdiction that Licensee requests that an application be submitted, (ii) pursue prosecution of such application that is included in such 

Distribution Rights, or (iii) maintain or renew any patents included in the Distribution Rights. Following such notice, Licensee may, with notice to Licensor, elect to apply for a patent in such jurisdiction, or continue the prosecution of such patent application (or maintenance of such patent) at Licensee’s expense, provided, however, that Licensor shall retain all ownership rights to any patents that may issue with respect to such Distribution Rights.

5. Third-Party Infringement.

5.1 A party receiving notice of alleged infringement of any Distribution Rights in the Territory, or having a declaratory judgment action alleging invalidity or non-infringement of any Distribution Rights in the Territory brought against it, shall promptly provide written notice to the other party of the alleged infringement or declaratory judgment action, as applicable.

5.2 Licensor shall bring suit or defend a declaratory judgment action and control the conduct thereof, including settlement, to stop infringement of any Distribution Rights, as determined solely by Licensor.

6. Compliance with Laws.

6.1 Marking. Licensee shall comply with the patent, copyright and trademark marking provisions of 35 U.S.C. § 287(a) by marking all commercial products and advertising  relating to the Distribution Rights with the appropriate symbols or word markings. Licensee shall comply with the intellectual property marking laws of each country in the Territory Licensee uses, markets or sells the Distribution Rights.

6.2 Regulatory Clearance. Licensor shall reasonably cooperate with Licensee in obtaining any clearances from governmental agencies to use, market or sell the Distribution Rights.

6.3 Recordation of License. Licensor shall record this Agreement as required by the laws of United States and any other countries as Licensee may request as a prerequisite to enforceability of this Agreement in the courts of such countries or for other reasons and any recordation fees, and related costs and expenses shall be at Licensee’s expense.

7. Confidentiality.

7.1 Confidentiality Obligations. Each party (the “Receiving Party”) acknowledges that in connection with this Agreement it will gain access to Confidential Information of the other party (the “Disclosing Party”). As a condition to being furnished with Confidential Information, the Receiving Party agrees, during the Term and all times thereafter, to:

(a) not use the Disclosing Party’s Confidential Information other than as strictly necessary to exercise its rights and perform its obligations under this Agreement; and

(b) maintain the Disclosing Party’s Confidential Information in strict confidence and, subject to Section 8.2, not disclose the Disclosing Party’s Confidential Information without the 

Disclosing Party’s prior written consent, provided, however, the Receiving Party may disclose the Confidential Information to its Representatives who:

	
(i)

	
have a “need to know” for purposes of the Receiving Party’s performance, or exercise of its rights with respect to such Confidential Information, under this Agreement;

	
(ii)

	
have been apprised of this restriction; and

	
(iii)

	
are themselves bound by written nondisclosure agreements at least as restrictive as those set forth in this Section 8, provided further that the Receiving Party shall be responsible for ensuring its Representatives’ compliance with, and shall be liable for any breach by its Representatives of, this Section 8.

The Receiving Party shall use reasonable care, at least as protective as the efforts it uses with respect to its own confidential information, to safeguard the Disclosing Party’s Confidential Information from use or disclosure other than as permitted hereby.

7.2 Exceptions. Notwithstanding anything to the contrary herein, Licensee shall be expressly permitted to reference this Agreement and the terms hereof in disclosure documents required by securities laws, and in other regulatory, administrative filings and public relations materials in the ordinary course of Licensee’s business, and in marketing materials relating to the Distribution Rights, without consent of the Licensor. Additionally, if the Receiving Party becomes legally compelled to disclose any Confidential Information, the Receiving Party shall:

(a) provide prompt written notice to the Disclosing Party so that the Disclosing Party may seek a protective order or other appropriate remedy or waive its rights under this Section 8; and

(b) disclose only the portion of Confidential Information that it is legally required to furnish.

If a protective order or other remedy is not obtained, or the Disclosing Party waives compliance, the Receiving Party shall, at the Disclosing Party’s expense, use reasonable efforts to obtain assurance that confidential treatment will be afforded the Confidential Information.

8. Representations; Warranties; Covenants.

8.1 Mutual Representations and Warranties. Each party represents and warrants to the other party that:

(a) it is duly organized, validly existing and in good standing as a corporation or other entity as represented herein under the laws and regulations of its jurisdiction of incorporation, organization or chartering;

(b) it has, and throughout the Term shall retain, the full right, power and authority to enter into this Agreement and to perform its obligations hereunder;

(c) the execution of this Agreement by its representative whose signature is set forth at the end hereof has been duly authorized by all necessary corporate action of the party; and

(d) when executed and delivered by such party, this Agreement shall constitute the legal, valid and binding obligation of that party, enforceable against that party in accordance with its terms.

8.2 Licensor’s Representations, Warranties, and Covenants. Licensor represents, warrants and covenants that:

(a) Licensor is the sole and exclusive owner of the Distribution Rights and has the right to grant Licensee the license granted under the Agreement, without any conflict or breach of any other material agreement or understanding between Licensor and any other entity;

(b) it has, and throughout the Term, will retain the unconditional and irrevocable right, power and authority to grant the license hereunder;

(c) neither its grant of the license, nor its performance of any of its obligations, under this Agreement does or will at any time during the Term:

	
(i)

	
conflict with or violate any applicable Law;

	
(ii)

	
require the consent, approval or authorization of any governmental or regulatory authority or other third party; or

	
(iii)

	
require the provision of any payment or other consideration to any third party.

(d) it has not granted and will not grant any licenses or other contingent or non-contingent right, title or interest under or relating to the Distribution Rights, or is or will be under any obligation, that does or will conflict with or otherwise affect this Agreement, including any of Licensor’s representations, warranties or obligations or Licensee’s rights or licenses hereunder;

(e) there neither are nor at any time during the Term will be any encumbrances, liens or security interests involving any Distribution Rights;

(f) no prior art or other information exists that would adversely affect the validity, enforceability, term or scope of any Distribution Rights;

(g) it has no knowledge after reasonable investigation of any settled, pending or threatened litigation or re-examination, post-grant or inter partes review, interference, derivation, 

opposition, claim of invalidity or other claim or proceeding (including in the form of any offer to obtain a license):

	
(i)

	
alleging the invalidity, misuse, un-registrability, unenforceability or non-infringement of any Distribution Rights;

	
(ii)

	
challenging Licensor’s ownership of, or right to practice or license, any Distribution Rights, or alleging any adverse right, title or interest with respect thereto; or

	
(iii)

	
alleging that the practice of any Distribution Rights or the making, using, offering to sell, sale or importation of any Distribution Rights in the Territory does or would infringe, misappropriate or otherwise violate any patent, trade secret or other intellectual property of any third party.

(h) it has no knowledge after reasonable investigation of any factual, legal or other reasonable basis for any litigation, claim or proceeding described in Section 9.2(g);

(i) it has not received any written, oral or other notice of any litigation, claim or proceeding described in Section 9.2(g); and

(j) it has not brought or threatened any claim against any third party alleging infringement of any Distribution Rights, nor is any third party infringing or preparing or threatening to infringe any patent, or practicing any claim of any patent application, included as a Distribution Rights.

9. Omitted

10. Indemnification.

10.1 Each party shall indemnify, defend and hold harmless the other party and its officers, directors, employees, agents, successors and assigns (each, an “Indemnitee”) against all Losses arising out of or resulting from any third party claim, suit, action or proceeding related to or arising out of or resulting from the party’s breach of any representation, warranty, covenant or obligation under this Agreement (each an “Action”).

10.2 Omitted.

10.3 Indemnification Procedure. The indemnified party shall promptly notify the indemnifying party in writing of any Action and cooperate with the indemnified party at the indemnifying party’s sole cost and expense. The indemnifying party shall immediately take control of the defense and investigation of the Action and shall employ counsel reasonably acceptable to indemnified party to handle and defend the same, at the indemnifying party’s sole cost and expense. The indemnifying party shall not settle any Action in a manner that adversely affects the rights of any indemnified party without the indemnified party’s prior written consent, 

which shall not be unreasonably withheld or delayed. The indemnified party’s failure to perform any obligations under this Section 11.3 shall not relieve the indemnifying party of its obligation under this Section 11.3 except to the extent that the indemnifying party can demonstrate that it has been prejudiced as a result of the failure. The indemnified party may participate in and observe the proceedings at its own cost and expense with counsel of its own choosing.

11. Term and Termination.

11.1 Term. This Agreement shall commence as of the Effective Date and, unless terminated earlier in accordance with Section 12.2, the licenses granted hereunder shall be perpetual (the “Term”).

11.2 Termination.  

(a) Licensor may terminate this Agreement on written notice to Licensee if Licensee materially breaches Section 4.1 of this Agreement and such breach remains uncured for twenty (20) days after Licensee receives written notice thereof.

(b) Licensee may terminate this Agreement at any time without cause, and without incurring any additional obligation, liability or penalty, by providing at least twenty (20) days’ prior written notice to Licensor.

(c) Either party may terminate this Agreement by written notice to the other party if the other party:

	
(i)

	
becomes insolvent or admits inability to pay its debts generally as they become due;

	
(ii)

	
becomes subject, voluntarily or involuntarily, to any proceeding under any domestic or foreign bankruptcy or insolvency law, which is not fully stayed within One Hundred Eighty (180) days or is not dismissed or vacated within One Hundred Eighty (180) days after filing;

	
(iii)

	
makes a general assignment for the benefit of creditors; or

	
(iv)

	
has a receiver, trustee, custodian or similar agent appointed by order of any court of competent jurisdiction to take charge of or sell any material portion of its property or business.

11.3 Effect of Termination. On termination of this Agreement, the Receiving Party shall (a) return to the Disclosing Party all documents and tangible materials (and any copies) containing, reflecting, incorporating or based on the Disclosing Party’s Confidential Information; (b) permanently erase the Disclosing Party’s Confidential Information from its computer systems and (c) certify in writing to the Disclosing Party that it has complied with the requirements of this Section 12.3.

11.4 Survival. The rights and obligations of the parties set forth in this Section 12.4 and Section 1 (Definitions), Section 8 (Confidentiality), Section 9 (Representations and Warranties), Section 11 (Indemnification), Section 12.3 (Effect of Termination), and Section 13 (Miscellaneous), and any right, obligation or required performance of the parties in this Agreement which, by its express terms or nature and context is intended to survive termination or expiration of this Agreement, will survive any such termination or expiration.

12. Miscellaneous.

12.1 Bankruptcy. The Parties acknowledge and agree that all rights and licenses granted pursuant to this Agreement are, for purposes of Section 365(n) of Title 11 of the United States Code (or any successor provision) (the “Bankruptcy Regulations”) “intellectual property” as defined in Section 101(35A) of the United States Bankruptcy Code (the “Code”), which has been licensed hereunder in a contemporaneous exchange for value.  The Parties further acknowledge and agree that if a Licensor becomes insolvent, applies for or consents to the appointment of a trustee, makes a general assignment for the benefit of its creditors, commences, or has commenced against it, any bankruptcy, reorganization, debt arrangement, or other proceeding under bankruptcy law or elects to reject this Agreement, or if this Agreement is deemed to be rejected, pursuant to Section 365 of the Code for any reason, this Agreement shall be governed 

by Section 365(n) of the Code and each Party as a Licensee hereunder will retain and may elect to fully exercise its rights under this Agreement in accordance with such Section 365(n).

12.2 Further Assurances. Each party shall, upon the request of the other party, promptly execute such documents and perform such acts as may be necessary to give full effect to the terms of this Agreement.

12.3 Independent Contractors. The relationship between the parties is that of independent contractors. Nothing contained in this Agreement shall be construed as creating any agency, partnership, joint venture or other form of joint enterprise, employment or fiduciary relationship between the parties, and neither party shall have authority to contract for or bind the other party in any manner whatsoever.

12.4 Omitted.

12.5 Notices. All notices and other communications hereunder shall be in writing and shall be deemed given when mailed, delivered personally, sent by facsimile (which is confirmed) or sent by an overnight courier service, such as Federal Express, to the parties at the following addresses (or at such other address for a party as shall be specified by such party by like notice):

If to Licensee, to:

The Chief Executive

Altitude International Inc

515 E Las Olas Boulevard Suite 120,

Ste 120,

Fort Lauderdale,

FL 33301,    USA

Tel: +1 954 256-5120

Email: TBA

If to Licensor, to:

The Managing Director

Sporting Edge UK Ltd

Unit J, Loddon Business Centre

Roentgen Road,

Basingstoke

RG24 8ng,   UK

Tel:    +44 1256 844484

email: dave.vincent@sportingedgeuk.com

12.6 Interpretation. For purposes of this Agreement, (a) the words “include,” “includes” and “including” shall be deemed to be followed by the words “without limitation”; (b) the word “or” is not exclusive; and (c) the words “herein,” “hereof,” “hereby,” “hereto” and “hereunder” refer to this Agreement as a whole.

Unless the context otherwise requires, references herein: (x) to Sections and Schedules refer to the Sections of and Schedules attached to, this Agreement; (y) to an agreement, instrument or other document means such agreement, instrument or other document as amended, supplemented and modified from time to time to the extent permitted by the provisions thereof; and (z) to a statute means such statute as amended from time to time and includes any successor legislation thereto and any regulations promulgated thereunder. This Agreement shall be construed without regard to any presumption or rule requiring construction or interpretation against the party drafting an instrument or causing any instrument to be drafted. Any Schedules referred to herein shall be construed with, and as an integral part of, this Agreement to the same extent as if they were set forth verbatim herein.

12.7 Headings. The headings in this Agreement are for reference only and shall not affect the interpretation of this Agreement.

12.8 Entire Agreement. This Agreement, together with all Schedules and any other documents incorporated herein by reference, constitutes the sole and entire agreement of the parties to this Agreement with respect to the subject matter contained herein, and supersedes all prior and contemporaneous understandings and agreements, both written and oral, with respect to such subject matter.

12.9 Assignment. Licensee may freely assign or otherwise transfer all or any of its rights, or delegate or otherwise transfer all or any of its obligations or performance, under this Agreement without Licensor’s consent. This Agreement is binding upon and inures to the benefit of the parties hereto and their respective permitted successors and assigns.

12.10 No Third-Party Beneficiaries. This Agreement is for the sole benefit of the parties hereto and their respective successors and permitted assigns and nothing herein, express or implied, is intended to or shall confer upon any other Person any legal or equitable right, benefit or remedy of any nature whatsoever, under or by reason of this Agreement.

12.11 Amendment; Modification; Waiver. This Agreement may only be amended, modified or supplemented by an agreement in writing signed by each party hereto. No waiver by any party of any of the provisions hereof shall be effective unless explicitly set forth in writing and signed by the waiving party. Except as otherwise set forth in this Agreement, no failure to exercise, or delay in exercising, any rights, remedy, power or privilege arising from this Agreement shall operate or be construed as a waiver thereof; nor shall any single or partial exercise of any right, remedy, power or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power or privilege.

12.12 Severability. If any term or provision of this Agreement is invalid, illegal or unenforceable in any jurisdiction, such invalidity, illegality or unenforceability shall not affect any other term or provision of this Agreement or invalidate or render unenforceable such term or provision in any other jurisdiction. Upon a determination that any term or other provision is invalid, illegal or unenforceable, the parties hereto shall negotiate in good faith to modify this 

Agreement so as to effect the original intent of the parties as closely as possible in a mutually acceptable manner in order that the transactions contemplated hereby be consummated as originally contemplated to the greatest extent possible.

12.13 Governing Law; Submission to Jurisdiction.  

(a) This Agreement and all related documents, and all matters arising out of or relating to this Agreement, are governed by, and construed in accordance with, the laws of the State of Nevada, United States of America, without regard to the conflict of laws provisions thereof to the extent such principles or rules would require or permit the application of the laws of any jurisdiction other than those of the State of Nevada.

(b) Any legal suit, action or proceeding arising out of or related to this Agreement or the licenses granted hereunder shall be instituted exclusively in the federal courts of the United States or the courts of the State of Nevada in each case located in the city of Las Vegas, and each party irrevocably submits to the exclusive jurisdiction of such courts in any such suit, action or proceeding. Service of process, summons, notice or other document by mail to such party’s address set forth herein shall be effective service of process for any suit, action or other proceeding brought in any such court.

12.14 Waiver of Jury Trial. Each party irrevocably and unconditionally waives any right it may have to a trial by jury in respect of any legal action arising out of or relating to this Agreement or the transactions contemplated hereby.

12.15 Equitable Relief. Each party acknowledges that a breach by the other party of this Agreement may cause the non-breaching party irreparable harm, for which an award of damages would not be adequate compensation and agrees that, in the event of such a breach or threatened breach, the non-breaching party will be entitled to equitable relief, including in the form of a restraining order, orders for preliminary or permanent injunction, specific performance and any other relief that may be available from any court, and the parties hereby waive any requirement for the securing or posting of any bond or the showing of actual monetary damages in connection with such relief. These remedies shall not be deemed to be exclusive but shall be in addition to all other remedies available under this Agreement at law or in equity, subject to any express exclusions or limitations in this Agreement to the contrary.

12.16 Attorney Fees. In the event that any action, suit, or other legal or administrative proceeding is instituted or commenced by either party hereto against the other party arising out of or related to this Agreement, the prevailing party shall be entitled to recover its reasonable attorneys’ fees and court costs from the non-prevailing party.

12.17 Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original, but all of which together shall be deemed to be one and the same agreement. A signed copy of this Agreement delivered by facsimile, e-mail or other means of electronic transmission (to which a signed PDF copy is attached) shall be deemed to have the same legal effect as delivery of an original signed copy of this Agreement.

 [SIGNATURE PAGE FOLLOWS]

IN WITNESS WHEREOF, each of the parties hereto has executed this License Agreement as of the date first above written.

LICENSEE:

Altitude International, Inc.

         

		By:	
/s/ Dave Vincent                                                 

Name: Dave Vincent

 Title: CEO

LICENSOR:

Sporting Edge UK Ltd., Inc.

              

		By:	
/s/ Dave Vincent                                                 

 Name: Dave Vincent

Title:  CEO

SCHEDULE 1

IP RELATING TO MANUFACTURING & SALES RIGHTS

Licensee is authorized to utilize:

	
·

	
all Intellectual Property owned by Sporting Edge UK Ltd.  This includes Designs, Software, Techniques, Market Intelligence and Know-How.

	
·

	
all Patents filed and Trademarks registered by Sporting Edge UK Ltd or to David Vincent.

Licensee is authorized to subcontract the manufacture and sale of products incorporating said IP, subject to the prior approval of the Managing Director of Sporting Edge UK Ltd.  Such approval not to be unreasonably withheld.

During the course of this agreement, all IP developed by the Licensee or the Licensor shall be made available to the other party at no cost.  Such IP shall be considered to be jointly owned and available for perpetuity by both parties.

SCHEDULE 2

SCHEDULE OF PAYMENTS

Payment Terms:

The Licensee shall pay to the Licensor on the Effective Date, and for 5 anniversaries of this date, the sum of $10,000 in lieu of Royalties.

SCHEDULE 3

ROYALTY FEES

The Royalty Fees that Licensee will pay to the Licensor are:

From the sixth anniversary of the Effective Date a royalty on all sales of product manufactured using the IP.  The royalty payable shall be calculated as 0.5% of the Sale Price.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00272-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00272-of-00352.parquet"}]]